Evidence map›Paper›PMID 24833881›Full record

ArticleWorld journal of gastroenterology2014

Proteomic identification of tumor biomarkers associated with primary gallbladder cancer.

Hai-Lin Huang, Hou-Shan Yao, Yi Wang, Wei-Jun Wang, Zhi-Qian Hu, Kai-Zhou Jin

Open access · hybridAbstract readValidation Study
In one paragraph

Article in World journal of gastroenterology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in genetics · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hai-Lin HuangHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Hou-Shan YaoHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Yi WangHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Wei-Jun WangHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Zhi-Qian HuHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Kai-Zhou JinHai-Lin Huang, Department of General Surgery, Hospital of China Armed Police Forces, Nanchang 330030, Jiangxi Province, China.
Police General Hospital · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo identify potential biomarkers of primary gallbladder cancer (PGC).

methodsFresh PGC, cholecystitis and normal gallbladder tissue specimens collected from 10 patients, respectively, were subjected to comparative proteomic analysis. The proteomic patterns of PGC were compared with those of cholecystitis and normal gallbladder tissues using two-dimensional gel electrophoresis (2-DE). The differentially expressed proteins were then identified using a MALDI-TOF mass spectrometer (MS) and database searches. To further validate these proteins, 20 samples of PGC tissues and normal tumor-adjacent tissues were collected for Western blot, quantitative real-time PCR, and immunohistochemical staining assay.

resultsSeven differentially expressed protein spots were detected by 2-ED analysis by comparing the average maps of PGC, cholecystitis and normal gallbladder tissues. Six of the seven differentially expressed proteins were identified using MALDI-TOF MS, with three overexpressed and three underexpressed in PGC tissue. Protein levels of annexin A4 (ANXA4) were significantly elevated, and heat shock protein 90-beta (Hsp90β) and dynein cytoplasmic 1 heavy chain 1 (Dync1h1) were decreased in PGC tissues relative to the normal tumor-adjacent tissues as shown by Western blot analysis. However, levels of actin, aortic smooth muscle and gamma-actin were unchanged. In addition, the mRNA levels of all 5 proteins showed similar changes to those of the protein levels (P < 0.01). Further validation by immunohistochemical analysis showed the upregulated expression of ANXA4 and decreased expression of Hsp90β and Dync1h1 in the cytoplasm of PGC tissues relative to the normal tumor-adjacent tissues.

conclusionThree proteins are identified as potential biomarkers of PGC using proteomic analysis. The functions of these proteins in the carcinogenesis of PGC remain to be studied.

Indexed as

ProteomicsAgedBiomarkers, TumorBlotting, WesternCase-Control StudiesDatabases, ProteinElectrophoresis, Gel, Two-DimensionalFemaleGallbladder NeoplasmsGene Expression Regulation, NeoplasticHumansImmunohistochemistryMaleMiddle AgedNeoplasm ProteinsPredictive Value of TestsBiomarkers, TumorNeoplasm ProteinsRNA, MessengerAnnexin A4BiomarkerDynein cytoplasmic 1 heavy chain 1Heat shock protein 90-betaPrimary gallbladder cancerProteomic analysis

Identifiers

PMID24833881
PMCPMC4017066
OpenAlexW2070088746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.